Product Description: Bifarcept is a recombinant antibody of interferon receptor type I (IFN-RI). Bifarcept can bind IFN-β and prolong its serum half-life[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Bilsborough J, et, al. From model to mechanism: lessons of mice and men in the discovery of protein biologicals for the treatment of inflammatory bowel disease. Expert Opin Drug Discov. 2006 Jun;1(1):69-83.